Laurence Reid, SVP, Chief Business Officer at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 13,500 shares at $53.36 ($720K) on 2013-11-13, disclosed to the SEC on 2013-11-15.
Scheduled sale ($720k) by SVP, Chief Business Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| ALNY | SELL | 2014-11-19 | $907K | — | Filing → |
| ALNY | SELL | 2014-08-20 | $909K | — | Filing → |
| ALNY | SELL | 2014-05-21 | $781K | — | Filing → |